Clinical trial · Interventional
The Effect of Endurance Training in Patients With Prostate Cancer
The Effect of Endurance Training on PSA Doubling Time, Body Composition, Insulin Sensitivity and Inflammation in Patients With Prostate Cancer
NCT01584960CI-TRIAL-00012785completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the present study is to investigate the effect of endurance on PSA doubling time in prostate cancer patients with an elevation in PSA following radical prostatectomy for localized cancer. Furthermore, underlying mechanisms such as reduction in inflammatory markers and improvement in insulin sensitivity and body composition are investigated.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Body Composition, Beneficial | — | UNRESOLVED | — |
| Insulin Sensitivity | — | UNRESOLVED | — |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| endurance training | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Prostate cancer, endurance training
- description
- Prostate cancer patients doing 2 years of home-based endurance training Cross over design with a control group with no intervention
- interventionNames
- Behavioral: endurance training
Primary outcomes (1)
- measure
- PSA doubling time
- timeFrame
- 2 years
Secondary outcomes (1)
- measure
- Insulin sensitivity, body composition and inflammation status
- timeFrame
- 0 months, 6 months and 24 months of training
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Prostate cancer patients with an increase in PSA following radical prostatectomy Exclusion Criteria: * severe cardiovascular disease * severe arthritis * severe neuropathy * severe hypertension * therapy with antidiabetic agents * other treatment for prostate cancer than radical prostatectomy
References
Publications (0)
Data not yet available
No reference posted for this study.